SOLANA BEACH, Calif., June 30, 2025 (GLOBE NEWSWIRE) -- Artelo Biosciences, Inc. (Nasdaq: ARTL), a clinical-stage pharmaceutical company focused on modulating lipid-signaling pathways to develop ...

Artelo reports favorable Phase 1 results for its FABP5 inhibitor, showing strong safety data and dose-dependent absorption in ...

High cholesterol is often dubbed the “silent killer” because it progresses for years without clear symptoms, until serious ...

Findings could help explain the links between macular degeneration and cardiovascular disease, which both worsen with age.

New research reveals that Alzheimer's disease may impair nerve function not by reducing myelin, but by altering the proteins ...

Investing.com -- Artelo Biosciences Inc (NASDAQ: ARTL) stock surged over 100% following favorable results from its first-in-human study evaluating ART26.12, a novel inhibitor of Fatty Acid Binding ...

A new study reveals that increasing levels of apolipoprotein M (ApoM) may slow or prevent the progression of age-related macular degeneration (AMD), a major cause of blindness in older adults.

Heart disease is the leading cause of death in the world, yet often its symptoms remain dormant for years, and only show up ...

Washington University researchers found that raising a molecule called ApoM helps eye cells sweep away harmful cholesterol ...

MIRA Pharmaceuticals, Inc. (NASDAQ:MIRA) on Monday revealed new animal study results from SKNY-1, a next-generation oral ...

Fixing problems with cholesterol metabolism might help slow or prevent a common cause of age-related vision loss, a new WashU ...

Many people with IBD, an umbrella term that includes ulcerative colitis and Crohn's disease, have a reduced quality of life, ...